Previous Close | 30.25 |
Open | 30.21 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 30.12 - 30.40 |
52 Week Range | 24.84 - 35.29 |
Volume | |
Avg. Volume | 644,019 |
Market Cap | 4.541B |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | 25.74 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.14 (3.77%) |
Ex-Dividend Date | Mar 13, 2024 |
1y Target Est | N/A |
Rayonier (RYN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
A solid timberland portfolio and developments in biogenetics and cloning are likely to aid Rayonier (RYN).
Third Avenue Management, an investment management company based in New York City, released its “Third Avenue Real Estate Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. In the calendar year, the fund returned +23.27% (after fees) versus +10.85% for the Fund’s most relevant benchmark, the FTSE EPRA […]